Bean1 overexpression resulted in a large rise in NLRP3 and IL-1β in CMECs following MI damage [87], suggesting that Bean1 may serve as a therapeutic target for NLRP3-mediated vascular injury in the treatment of MI. Here, IL1B is linked to myocardial infarction.